Radiation therapy is used to treat more than one million cancer patients each year. Yet, funding for radiation oncology research is limited.
ROI advances research and education so that patients with cancer can receive high-quality, innovative radiation treatment that enhances their quality of life and ultimately, saves more lives.
Founded in 2006 by the American Society for Radiation Oncology (ASTRO), ROI is a 501(c)(3) charity that has funded $4.3 million in research to improve outcomes for cancer patients and drive the field of radiation oncology forward.
Celebrate an outstanding early career researcher who is accelerating bold and innovative ideas in radiation therapy. Nominations for the 2024 ROI Publication Excellence Awards are due by July 5.
ROI recently overhauled the RadOnc Toolbox, a point of care reference to support evidence-based practice. The updated app puts ASTRO guidelines, a collection of calculators and nomograms, dose constraints, toxicity scales and many more oncology resources at your fingertips.
When you support ROI, you are driving research to increase the understanding and awareness of radiation therapy, helping to uncover treatment and cures and advancing radiation treatment that will improve quality of life and outcomes for patients with cancer.